In this study, we investigated the role of E1AF, a member of ets family transcription factor, in the acquisition of metastatic capacity by non-metastatic mouse ®brosarcoma cell clone, QR-32. The QR-32 cell clone grows progressively after co-implantation with gelatin sponge in syngeneic C57BL/6 mice. The cell lines (QRsP) established from arising tumors after the co-implantation exhibited enhanced tumorigenicity and pulmonary metastasis in vivo as compared with parent QR-32 cells. The enhanced pulmonary metastasis of QRsP cells was correlated well with augmented production of matrix metalloproteinase-2 (MMP-2) and increased expression of membrane-type 1-MMP (MT1-MMP). The QRsP cells also acquired higher chemokinetic activities to ®bronectin and higher invasive activities through a reconstituted basement membrane. Furthermore we observed the elevated mRNA expression of E1AF in QRsP cells compared to parent QR-32 cells. Therefore, we transfected QR-32 cells with E1AF cDNA. Overexpression of E1AF in the QR-32 cells resulted in the induction of MT1-MMP expression and converting an exogenously added precursor MMP-2 into active form. E1AF transfectants exhibited more motile and invasive activities, and moderately increased pulmonary metastatic activities than parental QR-32 cells in vivo, although their metastatic activities were lower than those of QRsP cells. These ®ndings suggest that the increased expression of E1AF in ®brosarcoma contributes to invasive phenotypes including MT1-MMP expression and enhanced cell migration, but not sucient for exhibiting highly metastatic activity in vivo.
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Keywords: mouse-®brosarcoma; metastasis; MMP-2; MT1-MMP; E1AF Metastasis, a major obstacle to the eective cancer therapy, is a complex multistep process (Liotta et al., 1991; Mignatti and Rifkin, 1993) . Degradation of basement membrane by producing imbalanced matrix-degrading proteinases or inducing production of proteinases by stromal cells is an essential step for tumor cells to invade and metastasize (Liotta et al., 1991; Mignatti and Rifkin, 1993; Birkedal-Hansen et al., 1993) . Among these proteolitic enzymes, matrix metalloproteinases (MMPs) play an important role in the invasive process of tumor cells by degrading various substrates within the extracellular matrix (ECM), (Liotta et al., 1991; Mignatti and Rifkin, 1993; Birkedal-Hansen et al., 1993; Crawford and Matrisian, 1996) .
We have previously reported that a mouse ®brosarcoma cell clone, QR-32, which by itself did not form tumors subcutaneously (s.c.) when implanted (2610 5 cells/mouse) in syngeneic C57BL/6 mice, grows progressively after s.c. co-implantation (1610 5 cells/ mouse) with a gelatin sponge (Okada et al., 1992) . The cell lines (QRsP) established from the tumors arising after the co-implantation exhibited biologically more malignant characteristics than those of parent QR-32 cells, such as enhanced s.c. tumorigenicity, lung metastatic capacity and production of prostaglandin E 2 (PGE 2 ) (Okada et al., 1992) . Gelatin sponge elicit an in¯ammatory response, which has been recognized to be a critical factor in tumor progression (Ascher et al., 1979; Rosen et al., 1995; Cerutti and Trump, 1991; Weitzman and Gordon, 1990) .
In this study, we focused on the expression of MMPs in ®brosarcoma cells and its relation to arti®cial metastasis. We found an elevated production of pro-MMP-2 (72 kDa type-IV collagenase/gelatinase A) and its detectable activated form in metastatic QRsP cell lines. MMP-2 has been repeatedly implicated in tumor metastasis as well as in primary tumor growth and angiogenesis (Birkedal-Hansen et al., 1993; Liotta et al., 1991; Stetler-Stevenson et al., 1993; Turck et al., 1996; Chambers and Matrisian, 1997) , and its activation was reported to be mediated by membrane-type 1-MMP (MT1-MMP) (Sato et al., 1994) . We also found the increased expression of MT1-MMP and E1AF, a member of the ets oncogene family, in the metastatic QRsP cell lines as compared to that in parental QR-32 cells. E1AF is a human homolog of mouse PEA3 (Higashino et al., 1995) . It was found that E1AF/PEA3 activates the promoters of dierent subclasses of MMP genes, including interstitial collagenase (MMP-1), stromelysin (MMP-3), and 92 kDa type IV collagenase (MMP-9/gelatinase B) (Higashino et al., 1995; Kaya et al., 1996) . It was also reported that E1AF/PEA3 enhances the motility of mammary epithelial and tumor cells by transactivation of vimentin promoter (Chen et al., 1996) . Therefore, we speculated that the E1AF/PEA3, as an oncogenic transcription factor, may be responsible for enhanced pulmonary metastatic activities of QRsP cell lines by promoting MMPs expression. Then we transfected QR-32 cells with E1AF cyclic DNA to investigate the contribution of E1AF expression to metastasis in mouse ®brosarcoma.
Progression of QR-32 cells after co-implantation with gelatin sponge
Parent QR-32 cells grew progressively after coimplantation with a gelatin sponge in six out of ten mice (60%). The cell lines (QRsP) established from arising tumors after the co-implantation displayed more malignant phenotypes compared with parent QR-32 cells in vivo, which is consistent with our previous results (Okada et al., 1992) . Among the six cell lines, ®ve lines exhibited signi®cantly increased pulmonary metastasis in vivo ( Table 1 ). The enhanced tumorigenic and metastatic capacities of QRsP cell lines were stable as far as they were maintained in tissue culture (data not shown).
Enhanced production of MMP-2 in highly metastatic QRsP cells
The gelatin substrate zymography analysis of serum-free conditioned medium (CM) revealed that parent QR-32 cells produced a great amount of MMP-9 (92 kDa band), but a very low level of MMP-2 (72 kDa band) as shown in Figure 1a (lane 1). , and -28 cell lines that showed high metastatic activities produced higher levels of MMP-2 and its active form (64 kDa band) (Figure 1a lanes 2, 3, 4, 6 and 7) than parent QR-32 cells. QRsP-26 cell lines that showed weakly metastatic capacity produced a lower amount of MMP-2 (Figure 1a lane 5) . MMP-9 levels in QRsP cell lines varied, but had no relation to metastatic capacity of QRsP cell lines. These bands were abolished when the gels were incubated with EDTA (data not shown).
Increased expression of MT1-MMP in metastatic QRsP cells
MT1-MMP is expressed on the cell membranes and activates the zymogen of MMP-2 Sato et al., 1994) . Northern blot analysis demonstrated that MT1-MMP was expressed in QR-32 cells at a very low level as shown in Figure 1b Figure 2b shows the relative levels of E1AF mRNA normalized to that of L38 mRNA by scanning densitometry. E1AF levels were elevated to 4.72-, 2.62-, 6.86-, 4.11-and 2.90-fold in high metastatic QRsP-23, -24, -25, -27, and -28 cell lines, respectively. E1AF expression was thus correlated with metastatic activity of the ®brosarcoma cells.
Increased expression of MT1-MMP in E1AF-transfectants
We next transfected QR-32 cells with an E1AF expression vector by the standard DNA-calcium phosphate coprecipitation method as described previously . Five out of 15 Geneticinresistant clones expressed exogenous E1AF mRNA (data not shown); among them three clones (QR-32/ E1AF-cl-1, -4, -10) were con®rmed by Northern blot assay to express higher levels of E1AF mRNA (data not shown). MT1-MMP mRNA was barely detected in parental QR-32 cells and control Neo-transfectants 4/5 (6,11,34,53) 3/5 (4,9,13) 1/5 (4) 3/4 (7,12,16) 4/5 (16, 21, 36, 41) 19/28 a Female C57BL/6 mice between 2 and 4 months of age were obtained from Japan SLC Inc., (Hamamatsu, Japan), and maintained in SPF conditions. b QR-32 cells (1610 5 /0.1 ml) were co-implanted with a gelatin sponge piece (106563 mm) according to the method previously reported (Okada et al., 1992) in syngeneic C57BL/6 mice. Growing tumors were resected on day 21 for establishment of cultured cell lines, which were named as respectively . These tumor cells were maintained as a monolayer culture in Eagle's minimum essential medium (MEM) containing 10% fetal calf serum (FCS), sodium pyruvate, non-essential amino acids and L-glutamine, at 378C in a humidi®ed 5% CO 2 /95% air mixture. (Figure 3a lanes 1, 2 and 3 ), but signi®cantly induced in E1AF transfectants ( Figure 3a lanes 4, 5 and 6). Zymographic analysis indicated that amounts of pro-MMP-2 and MMP-9 in CM of E1AF transfectants as well as in control Neo-transfectants were not included ( Figure 3b ). Though expression of MT1-MMP in E1AF transfectants was signi®cantly increased, active form of MMP-2 was not detectable by Zymographic analysis (Figure 3b ). Human embryonic ®broblast MRC5 secretes a large amount of 72 kDa pro-MMP-2 into CM (Figure 3c lane 8) . Therefore, we added the serumfree CM of MRC5 to 80 ± 90%-con¯uent QR-32 cells, control transfectants and E1AF transfectants, respectively, and further incubated for 36 h. Then the CM was harvested and subjected to gelatin zymography. As shown in Figure 3c , pro-MMP-2 was processed into the active form of 64 kDa in E1AF transfectants (lanes 5, 6, and 7), but not in QR-32 cells (lane 2) and control transfectants (lanes 3 and 4), indicating that E1AF-transfectants acquired the activity that converted pro-MMP-2 into the active form.
Enhanced motile and invasive activities in E1AF transfectants and in QRsP cells
We examined the chemotaxis of QR-32 cells, Neotransfected clones, E1AF-transfected clones and QRsP-23, -24, -25 cell lines to ®bronectin, using transwell chamber with non-coated ®lters. As shown in Table 2 , -23, -24, -25, -26, -27, -28 cell lines (lanes 2, 3, 4, 5, 6 and 7, respectively) . Conditioned medium (CM) were obtained by incubating cells for 24 h at con¯uence in serum-free MEM. CM samples were electrophoresed in a nonreducing 7.5% SDS-polyacrylamide gel containing 0.1% (w/v) gelatin. The gel was washed at room temperature for 2 h in the presence of 2.5% Triton X-100 to remove the SDS and then incubated at 378C for 36 h in a buer containing CaCl 2 10 mM, NaCl 150 mM, Tris-HCl 50 mM (pH 7.5) and NaN 3 0.02%. The gel was then stained for protein with 0.1% Coomassie Brilliant Blue R-250 (Bio-Rad) and photographed on a light box. Gelatinolytic activities were visualized as a white zone in a dark ®eld. (b) Northern blot analysis of MT1-MMP mRNA expression in QR-32 cells (lane 1) and in 3, 4, 5, 6 and 7, respectively) . Total RNA was isolated with TRIZOL Reagent (Gibco-BRL, Tokyo, Japan). The RNA (20 mg) was electrophoresed in 1.0% agarose gel containing 2.2 M formaldehyde in MOPS-running buer, transferred onto a nitrocellulose ®lter and then baked at 808C for 2 h. Pre-hybridization was carried out in hybridization buer containing 50% Formamide, 56SSPE, 0.5% SDS, 56Denhardt's solution and 100 mg/ml denatured salmon sperm DNA for 2 h at 428C. Hybridization was carried out in the same solution containing 5 ng/ml probe labeled with 32 P-dCTP by random priming kits (Amersham, Tokyo, Japan). The ®lters were washed twice with 26SSC/0.1% SDS at room temperature, twice with 0.26SSC/0.1% SDS at 558C, and then exposed to X-ray ®lm at 7808C for an appropriate time (Taguchi et al., 1997) . The probes were stripped by heating up to 908C for 15 min in 0.16SSC/0.1% SDS, and reprobed with 32 Plabeled L38 cDNA. L38 is an internal marker for applied RNA amounts . L38 is an internal marker for applied RNA amounts. (b) Relative amount of E1AF mRNA. The intensities of E1AF bands were measured by scanning densitometry, and then the relative level of E1AF was normalized to L38 E1AF functions in experimental fibrosarcoma metastasis H Habelhah et al an average of 130 cells/®eld/6 h of E1AF transfectants migrated to the lower surface of the ®lter as compared to about 6 cells/®eld/6 h of QR-32 cells migrated (P50.01). In contrast, more than 200 cells/®eld/6 h of QRsP-23, -24, -25 cell lines migrated to the lower surface of the ®lter (P50.001 vs QR-32). Next, we examined the invasive activities of these cells through a reconstituted matrigel membrane model. As shown in Table 2 , an average of 50 cells/®lter/48 h of E1AF transfectants invaded through the matrigel membrane as compared to very few cells of QR-32 and Neotransfectants (P50.01) invaded. However, more than 250 QRsP-23, -24, -25 cells per ®lter/48 h invaded through the matrigel membrane (P50.001 vs QR-32).
Metastatic capacity of E1AF transfectants
E1AF transfectant cells and control cells were inoculated intravenously into normal syngeneic C57BL/6 mice (1610 5 cells/mouse). As shown in Table 3 , E1AF transfectants acquired moderately increased lung colonizing ability compared to parental cells. Whereas the metastatic activities of E1AF transfectants were rather lower than QRsP cell lines (Table 1) .
Enhanced pulmonary metastasis of QRsP cell lines correlated well with their elevated secretion of MMP-2 and increased expression of MT1-MMP and E1AF. However, overexpression of E1AF in parent QR-32 cells by E1AF-expression-vector transfection did not result in an augmented secretion of MMP-2 or MMP-9 in QR-32 cells, though transfection of human breast cancer cell line MCF-7 with the E1AF-expressionvector resulted in an increase in MMP-9 gene expression . One possibility is that MMP-9 was secreted at a high level prior to E1AF gene transfection in QR-32 cells. Since the promoter region of MMP-2 has no E1AF/PEA3-binding site (Crawford and Matrisian, 1996; Matrisian, 1994) , we speculate that the increased expression of MMP-2 and E1AF in QRsP cell lines was regulated by independent pathway or they are downstream events of some other upstream factor. E1AF/PEA3 is overexpressed in various metastatic cancer cells (Baert et al., 1997; Shindoh et al., 1996; Taguchi et al., 1997; Trimble et al., 1993; Wasylyk et al., 1993) , and its activity is reported to be regulated by two distinct mitogenactivated protein kinases independently (O'Hagan et al., 1996) . MMP-2 is expressed in many cell types constitutively and does not respond to phorbol esters, growth factors and in¯ammatory cytokines on account of the absence of AP-1, PEA3, TIE and other regulatory sequences within the 5'-¯anking region (Crawford and Matrisian, 1996; Matrisian, 1994) . Nevertheless, MMP-2 is also upregulated in various metastatic cancer cells (Birkedal-Hansen et al., 1993; Liotta et al., 1991; Mignatti et al., 1993; StetlerStevenson et al., 1993) , as well as in the QRsP cell lines (Figure 1 ). Transforming growth factor-b1 (TGF-b1) and Concanavalin A (Con A) were reported to upregulate MMP-2 expression in human ®broblasts and keratinocytes (Overall et al., 1991; Salo et al., 1991; Overall and Sodek, 1990) . H-ras oncogene-transformed human bronchial epithelial cells secrete MMP-2 which is not found in the normal parental cells (Collier et al., 1988) . Calcium in¯ux also modulates MMP-2 production (Kohn et al., 1994) . These evidences suggested that additional levels of transcriptional control rested within the intrinsic MMP-2 promoter. Our results provided with the evidence that MMP-2 was up-regulated in 2 and 3, respectively) of control Neo-transfectants and QR-32/E1AF-cl-1, -4, -10 clones (lanes 4, 5 and 6, respectively). Total RNA (20 mg) was isolated and detected with 32 P-labeled E1AF and MT1-MMP probes. L38 is an internal marker for applied RNA amounts. (b) MMP-9 (92 kDa bands) and MMP-2 (72 kDa bands) productions in QR-32 cells (lane 1), QR-32/Neo-cl-1, -2 clones (lanes 2 and 3, respectively) and QR-32/ E1AF-cl-1, -4, -10 clones (lanes 4, 5 and 6, respectively). CM samples were obtained by incubating the cells for 24 h at con¯uence in serum-free MEM, and then subjected to gelatin Zymography. (c) Conversion of pro-MMP-2 into the active 64 kDa form in E1AF transfectants. Serum-free CM of MRC5 ®broblasts was added to 80 ± 90% con¯uent QR-32 cells and transfectant cells. After 36 h incubation, CM was harvested and subjected to gelatin Zymography. Lane 1 represents CM of QR-32, and lane 2 to lane 7 represent QR-32, QR-32/Neo-cl-1, -2, QR-32/ E1AF-cl-1, -4, -10 cells incubated with CM of MRC5, respectively. Lane 8 represents CM of MRC5, and lane 9 CM of MRC5 incubated with 1.5 mM aminophenylmercuric acetate (APMA) at 378C for 2 h which was used as control for active form of MMP-2 E1AF functions in experimental fibrosarcoma metastasis H Habelhah et al mouse ®brosarcoma after co-implantation with gelatin sponge which might be promoted by host cells reactive to foreign body. As other MMPs, MMP-2 is secreted as an inactive zymogen and readily complexes with tissue inhibitor of matrix metalloproteinase-2 (TIMP-2). At protein level, MMPs activity is also tightly regulated by the action of TIMPs Crawford and Matrisian, 1996; Overall, 1994) . TIMP-1 and TIMP-2 expressions were detected in QR-32 cells and QRsP cell lines at relatively similar levels (data not shown). But both TIMP-1 and TIMP-2 expressions had no apparent correlation with metastatic activities of QRsP cell lines. Many studies have implicated that MMP-2 is localized on cell surface invadopodia by its ability to bind directly to integrin avb3 (Monsky et al., 1993; Brooks et al., 1996) and that its activation is mediated by MT1-MMP (Sato et al., 1994 Ohuchi et al., 1997) . Activated MMP-2 not only digests type IV collagen to facilitate cell invasion, but also induces cell migration by cleavage of laminin-5 (Giannelli et al., 1997) . In present study, the increased production of MMP-2 from high metastatic QRsP cell lines was also processed to active form of 64 kDa (Figure 1a ), which showed a linear correlation with the increased MT1-MMP expression in these cells ( Figure  1b) . MT1-MMP is expressed both in carcinoma cells and in surrounding stromal ®broblasts (Sato et al., 1994; Okada et al., 1995) . Overexpression of E1AF gene resulted in the elevated expression of MT1-MMP in QR-32 cells. Notably, E1AF-transfectant cells exhibited the activity that converting pro-MMP-2 into the active form. As far as our knowledge is concerned, this is the ®rst time to demonstrate that E1AF induces MT1-MMP expression in tumor cells. At present, we do not know whether E1AF binding site exist in the promoter region of MT1-MMP gene. Several reports by others implicated that phorbol 12-myristate 13-acetate, Con A, interleukin-1, tumor necrosis factor-a treatment elevate MT1-MMP mRNA levels in human ®broblasts, ®brosarcoma and chondrocytes (Lohi et al., 1996; Imai et al., 1997) . These results indicate that MT1-MMP gene expression is responsive to growth stimulating factors or in¯ammatory cytokines in these cell types. In dog kidney epithelial cells, MT1-MMP expression was induced by v-src transformation (Kadono et al., 1998) . In present study, although we have no direct evidence demonstrating that E1AF could transactivate MT1-MMP gene promoter by itself, E1AF, at least co-operatively with other transcription factors or indirectly transactivating other transcription factors, up-regulate MT1-MMP gene expression in mouse ®brosarcoma.
QR-32 cells transduced with E1AF cDNA showed higher chemotaxic activities to ®bronectin and invasive activities through matrigel (Table 2) . Our results support the previous reports that the overexpression of E1AF enhanced the motility of several tumor cells (Chen et al., 1996; Kaya et al., 1996) . These results indicated that E1AF not only increases MMP expression, but also transactivates motility-related factors to enhance invasion of tumor cells. However, 4 tumor cells were suspended in 0.2 ml serum-free MEM, and placed into the upper chamber of 6.5 mm diameter and 8 mm pore-size transwells (Costar Corp., Cambridge, USA). The lower chamber contained 0.7 ml serum-free MEM and 25 mg/ml ®bronectin as a chemoattractant. The cells were incubated for 6 h at 378C in a CO 2 incubator. At the end of the incubation, the cells were ®xed in 5% glutaraldehyde/PBS for 30 min and stained with Giemsa solution. The cells on the upper surface of the ®lter were completely removed by wiping with a cotton swab. The cells that had moved to the lower surface of the ®lter were counted at ten dierent ®elds under a light microscope at a magni®cation of 6100. Each assay was done in triplicate. Signi®cant dierences were determined by Student's t-test. The ®lters of transwell chambers were coated with 156 mg/cm 2 MATRIGEL Matrix (Becton Dickinson, MA, USA) that was sucient to form a continuous even barrier (Albini et al., 1987) . 2610 4 tumor cells were suspended in 0.2 ml MEM containing 10% FCS, and placed into the upper chamber. The lower chamber contained 0.7 ml MEM containing 10% FCS and 25 mg/ml ®bronectin as a chemoattractant. The cells were incubated for 48 h at 378C in a CO 2 incubator. All the cells that had moved to the lower surface of the ®lter were counted under a light microscope at a magni®cation of 6100. Each assay was done in triplicate. Signi®cant dierences were determined by Student's t-test. *P50.01 as compared to QR-32. **P50.001 as compared to QR-32 the motile and invasive activities of E1AF transfectants were lower than those of QRsP cell lines (Table 2) . E1AF transfectants also acquired the lung metastatic activities, but their colony number was much lower than that of QRsP cell lines, which indicates that enhanced production of MT1-MMP alone was not sucient for acquisition of high metastatic capacity in QR-32 cells. Presumably other factors such as the one that induces the increased production of MMP-2 would be needed for the acquisition of in vivo metastatic ability to the level of the progressor QRsP cells.
